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Abstract
Background: Studies of cancer incidence and early management will increasingly draw on routine
electronic patient records. However, data may be incomplete or inaccurate. We developed a
generalisable strategy for investigating presenting symptoms and delays in diagnosis using ovarian
cancer as an example.
Methods: The General Practice Research Database was used to investigate the time between first
report of symptom and diagnosis of 344 women diagnosed with ovarian cancer between 01/06/
2002 and 31/05/2008. Effects of possible inaccuracies in dating of diagnosis on the frequencies and
timing of the most commonly reported symptoms were investigated using four increasingly
inclusive definitions of first diagnosis/suspicion: 1. "Definite diagnosis" 2. "Ambiguous diagnosis" 3.
"First treatment or complication suggesting pre-existing diagnosis", 4 "First relevant test or
referral".
Results: The most commonly coded symptoms before a definite diagnosis of ovarian cancer, were
abdominal pain (41%), urogenital problems(25%), abdominal distension (24%), constipation/change
in bowel habits (23%) with 70% of cases reporting at least one of these. The median time between
first reporting each of these symptoms and diagnosis was 13, 21, 9.5 and 8.5 weeks respectively.
19% had a code for definitions 2 or 3 prior to definite diagnosis and 73% a code for 4. However,
the proportion with symptoms and the delays were similar for all four definitions except 4, where
the median delay was 8, 8, 3, 10 and 0 weeks respectively.
Conclusion: Symptoms recorded in the General Practice Research Database are similar to those
reported in the literature, although their frequency is lower than in studies based on self-report.
Generalisable strategies for exploring the impact of recording practice on date of diagnosis in
electronic patient records are recommended, and studies which date diagnoses in GP records need
to present sensitivity analyses based on investigation, referral and diagnosis data. Free text
information may be essential in obtaining accurate estimates of incidence, and for accurate dating
of diagnoses.
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Recent findings from three large international studies [1-
3] suggest that the UK compares poorly with other coun-
tries in term of cancer survival. The reasons for this are not
fully understood but may be due partly to delays in diag-
nosis and/or treatment after first onset of related symp-
toms, either because patients do not report their
symptoms (patient delay), or because GP do not refer
them quickly when they do (primary care delay). It is clear
that a more thorough understanding of the extent and
determinants of delay will be needed if cancer survival
rates in the UK are to be improved [4], especially as the
NHS cancer plan for England is now being questioned
[5,6]. Mapping out routes from first symptom to diagno-
sis is currently the focus of much effort and is one of the
main remits of a National Audit, within the National
Awareness and Early Diagnosis initiative (NAEDI)) [7].
Although a number of studies have examined the different
components of diagnostic delay in UK cancer patients, most
notably the literature review and study by Allgar and Neal
[8], many studies are based on small numbers and rely on
patient interviews or surveys which may be subject to recall
and non-response bias. In this study we investigate the
potential and pitfalls of using records from a large UK pri-
mary care database, the General Practice Research Database
(GPRD), for investigating such delays using ovarian cancer as
the exemplar. Ovarian cancer was selected because diagnosis
in its early stages greatly increases the probability of survival
[9]. Although it is often thought of as an initially symptom-
less disease, there is increasing evidence that patients experi-
ence a number of symptoms, particularly abdominal and
urogenitary symptoms before actual diagnosis [10-12].
In the UK, all residents are required to be registered with
a General Practitioner who is the "gatekeeper" for special-
ist investigations and treatments undertaken in the
National Health System. Thus, most women with this can-
cer will contact their general practitioner (GP) in the first
instance [13,14], but there may be some delay between a
patient first reporting to the GP and referral and diagnosis
[13,15].
The GPRD [16] is one of the largest primary care databases
in the UK. It contains anonymised longitudinal data on a
representative sample of about 6% of the UK population
– 3 million currently registered patients and over 8 mil-
lion historic patients. The GPRD collects data from about
450 general practices throughout the UK and is widely
used in research on disease epidemiology, drug safety and
adverse drug reactions. Access to anonymised free text
data is available in the database but at considerable addi-
tional cost. The main goals of the present study are to
investigate the distribution of symptoms most commonly
reported to the GP prior to ovarian cancer diagnosis, and
to quantify the time between presentation of symptoms
and diagnosis. Originally we planned to base our calcula-
tions on the first date that ovarian cancer was recorded (in
common with previous studies of cancer symptoms using
UK primary care records [17-20]). However, preliminary
examination of individual records indicated that the first
recorded code for ovarian cancer may not reliably indicate
the date of diagnosis. Electronic patient recording in gen-
eral practice allows flexible recording to take place and
subsequently the completeness and accuracy of coded
data is often variable [21]. In some instances, information
may be stored only implicitly and it is not uncommon to
find the actual diagnosis of a condition recorded at a late
stage in the disease. In recognition of this fact, the main
focus of the work reported in this paper is to explore alter-
native diagnostic dating methods for ovarian cancer using
a number of working definitions to develop a generalisa-
ble strategy for analysis.
Methods
Data and measures used
Data
The GPRD dataset was provided under the MRC licence
scheme and access to the dataset was approved by the
Independent Scientific Advisory Committee (Protocol
07_069). The target population consisted of all females
between 40 and 80 years of age who were alive and regis-
tered in the GPRD on June 1, 2002. From this population,
all women with an incident diagnosis of ovarian cancer
recorded during June 1, 2002 – May 31, 2007 were iden-
tified. Women with a previous definite or closely related
diagnosis of ovarian cancer (Table 1) were excluded from
the cohort. A medical diagnosis of ovarian cancer was
defined by a Read or OXMIS code for this condition
recorded in the patient's clinical or referral record i.e. Read
codes: B440.00 (Malignant neoplasm of ovary) B440.11
(Cancer of ovary) or B44..00 (Malignant neoplasm of
ovary and other uterine adnexa) or OXMIS codes: 1830A
(Malignant neoplasm ovary), 1830AD (adenocarcinoma
ovary), 1830C (Carcinoma ovary), 1830MC (mucinous
cystadenocarcinoma ovary). Read codes (which have
superseded the OXMIS codes) were specifically developed
for use in UK primary care by Dr James Read during the
1980s are used to record all medical events in clinical
practice. The Read code links alphanumeric labels to dis-
eases and symptoms, allowing details of consultations to
be entered and abstracted. Diagnostic codes start with a
letter whereas symptoms, signs, investigations, proce-
dures and administration tasks start with a number.
Denominator data was provided to enable calculation of
rates of a first definite diagnosis of ovarian cancer in the
GPRD. This included information on patient count and
number of person years stratified by calendar year, age,
gender and practice.Page 2 of 9
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selected to evaluate the current study objectives (data from
the remaining practices will be used as validation data for
testing the prognostic models which will be developed in the
next stage of this work). The records from the 127 practices
included 374 patients with a definite code for ovarian cancer.
Of these 344 patients were used for this study after excluding
3 cases with a prior ambiguous diagnosis before the study
period (1 "ovarian cystadenoma or carcinoma" and 2 "ovar-
ian stromal tumour") and 27 patients who had been regis-
tered with the GP for less than 2 years before diagnosis.
Measures
The most commonly recorded ovarian cancer related
symptoms were identified using a list of Read codes for
commonly reported symptoms [12,22], drawn up with
the help of a gynaecological oncologist (AM). Symptoms
were subsequently categorized as follows. and grouped
into the following 12 categories: 1. Abdominal pain, 2.
Pelvic pain, 3. Back pain, 4. Abdominal distension/bloat-
ing, 5. Indigestion, 6. Nausea and Vomiting, 7. Constipa-
tion Change in bowel habits, 8. Urogenital Symptoms, 9.
Abdominal mass, 10. Appetite Weight, 11. Tiredness, 12.
Breathing problems. The percentage with symptoms and
time between first relevant symptom and diagnosis code
were assessed according to these categories.
Codes for relevant investigations and referrals for ovarian
cancer were categorised into 5 groups: 1. Oophorectomy
2. Laparotomy or laparoscopy 3. Ultrasound 4. CA12 5.
Referral to Gynaecologist. In order to pick up any codes
for relevant symptoms, investigations or referrals which
may have been missed, we examined the anonymised
records of individual patients in the six-month period
before definite diagnosis date, and also tabulated the
most commonly occurring Read codes in order of fre-
quency. The code list for the four categories listed in the
section on sensitivity analysis below, and the category for
'cancer from other sites' was created by merging the clini-
cal and referral records for the cases in the defined time
periods with a comprehensive list of all cancer codes. The
descriptions for the merged events were then inspected by
the authors and assigned to the appropriate category.
The code lists used in this paper, including a list used to
identify patients who had previously been diagnosed
with, or treated for another type of, cancer are provided in
the additional material (additional file 1, 2 and 3). The
Table 1: READ codes for definite and very closely related diagnosis of ovarian cancer.
READ code Name
Definite diagnosis
B440.00 Malignant neoplasm of ovary
B440.11 Cancer of ovary
B44..00 Malignant neoplasm of ovary and other uterine adnexa
Very closely related diagnosis
BB81.00 [M]Ovarian cystic, mucinous and serous neoplasms
BB81.11 [M]Ovarian cystadenoma or carcinoma
BB81.12 [M]Ovarian mucinous tumour
BB81.13 [M]Ovarian papillary tumour
BB81.14 [M]Ovarian serous tumour
BBC0.12 [M]Ovarian stromal tumour
B4...00 Malignant neoplasm of genitourinary organ
B4...11 Carcinoma of genitourinary organ
B553.00 Malignant neoplasm of pelvis
B553z00 Malignant neoplasm of pelvis NOS
B912.00 Neoplasm of uncertain behaviour of ovary
B913z00 Neoplasm of uncertain behaviour of female genital organs NOS
BB81200 [M]Serous cystadenocarcinoma, NOS
BB81800 [M]Papillary serous cystadenocarcinoma
BB81B00 [M]Serous surface papillary carcinoma
BB81E00 [M]Mucinous cystadenocarcinoma NOS
BB81H00 [M]Papillary mucinous cystadenocarcinoma
BB82.00 [M]Mucinous adenoma and adenocarcinoma
BB82100 [M]Mucinous adenocarcinoma
D212000 Anaemia in ovarian carcinoma
The definite diagnosis codes were used to select the cases for the study. The closely related diagnosis codes were use to exclude cases, who had a 
diagnosis prior to the study period.Page 3 of 9
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investigations and referrals is available as additional file 4.
Data analysis
The number of cases diagnosed with ovarian cancer in
each year in the study was calculated by dividing the
number of first-time definite diagnoses codes for ovarian
cancer by the corresponding person years for that year for
the total study population. The rates were stratified by 5-
year age bands and were compared with the "Registrations
of cancer diagnosed in 2004, England" and "Registrations
of cancer diagnosed in 2005, England" as reported by the
Office of National Statistics (ONS) [23,24]. The incidence
of major categories of commonly reported symptoms was
estimated for each time period by dividing the number of
patients reporting each symptom at least once in the given
time period by the number of patients. Software: Data
management was undertaken using MySql http://http:/
www.mysql.com and statistical analyses were performed
using Stata 10 ((Stata Corporation, Texas, USA). Hard-
ware: Apple Mac Pro.
Sensitivity of delay in relation to different definitions of 
index date
In order to determine the possible effects of inaccurate
dating on the estimates of percentage of symptoms and
delays, a sensitivity analysis was carried out using 4 alter-
native categories of Read codes indicating a diagnosis of,
or investigation for ovarian cancer.
Category 1. Definite diagnostic code only Read codes
for a case of ovarian cancer or malignant primary
ovarian neoplasm as defined above ("definite diagnosis"
in Table 1).
Category 2. More general "ambiguous" code which
could indicate diagnosis of ovarian cancer This category
included ambiguous but very closely related Read code
indicating possible ovarian cancer ("very closely related
diagnosis" in Table 1) together with at least one more gen-
eral codes such as "Cancer", "Secondary neoplasm of
other specified sites" and "Carcinomatosis"
Category 3. Cancer treatment or referral code All codes
indicating a prior cancer diagnosis e.g "cancer care
review", "chemotherapy", referral to oncologist.
Category 4. Investigation or referral code for suspected
ovarian cancer This category included codes for a relevant
investigation (e.g ultrasound scan, CA125 test), diagnos-
tic procedure (e.g. oophorectomy) or referral to gynaecol-
ogist. This definition was included in order to identify
when the GP was first recorded as taking action to investi-
gate the ovarian cancer.
Four index dates based on these categories were con-
structed for each case, in order of increasing inclusivity,
beyond the first Read code indicating a definite diagnosis
of ovarian cancer.
Date 1 Earliest recorded date of definite diagnostic code
(Category 1)
Date 2 Date 1, or, if present, the first date of an "ambigu-
ous" code (Category 2) if this occurs prior to but within
two years of Date 1. If another type/site of cancer has been
diagnosed any time during the 4 years prior to the event-
date associated with a generic cancer code (e.g. "Cancer"
or "Carcinomatosis" preceded by "Multiple myeloma")
then it will be assumed that the code refers to this previ-
ous type of cancer and Date 1 will be used
Date 3 Date 2, or, if present, first date of code indicating
GP already knew of a cancer diagnosis (Category 3) if this
occurs prior to but within two years of Date 2. If another
type/site of cancer has been diagnosed any time during
the 4 years prior to the eventdate associated with such a
code, then it will be assumed that the code refers to this
previous type of cancer and Date 2 will be used – e.g Date
3 for a patient with "cancer care review" preceded by "can-
cer of the breast" will be Date 2.
Date 4 Date 3, or, if present, first date of a investigation or
referral to a gynaecologist if this is earlier than but within
12 months of Date 3. N.B. this is slightly different and
captures referral if present so while dates 1 to 3 are likely
to be the same for most cases, 4 will generally be different
as most will have had an investigation or referral code
prior to a diagnosis.
Results
Number of women definite ovarian cancer codes in the 
entire GPRD
The total number of women aged between 40 and 80 at
the beginning of the defined study period with a first
unambiguous diagnosis of ovarian cancer recorded in the
GPRD between June 1, 2002 – May 31, 2007 was 1166.
All of these had Read (as opposed to OXMIS) codes. Table
2 shows the rate for each year. These rates were approxi-
mately 10% lower than the incidence rates reported by the
Office of National Statistics (ONS) [23,24], for most age
groups except for women aged between 75–80 years at
diagnosis, when the the rates were approximately 30%
lower.
Investigation of symptoms prior to definite diagnosis (Date 
1) for the 344 selected patients
Incidence of symptoms
Three hundred cases (87%) were recorded as having had
at least one of most commonly coded ovarian cancerPage 4 of 9
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commonly coded ovarian cancer related symptoms in the
12 months before diagnosis was abdominal pain (41%),
followed by urogenital problems(25%), abdominal dis-
tension (24%), and constipation/change in bowel habits
(23%), with 70% of cases reporting at least one of these.
The percentage recorded as experiencing symptoms was
much higher in the 3 months before diagnosis (69%)
than in the preceding quarters (Figure 1). The other most
commonly reported symptoms were cough (12%) and
chest infection (6%).
Time between reporting symptoms and definite diagnosis
The median time in weeks between first recording a symp-
tom and definite diagnosis was 19.5 for any symptom (n
= 300), 13 for abdominal pain (n = 141), 21 for urogenital
problems (n = 86), 9.5 for abdominal distension (n = 84)
and 8.5 for constipation (n = 80).
Table 2: Number of episodes of a first recorded definite ovarian cancer code in the GPRD from 01/06/2002–01/06/2007 inclusive, 
among women aged between 40–80 at the start of this period
Year Cases Rate per 100,000 of first recorded code Registered Person years
2002 129 31.1 726432 414439
2003 220 31.1 743517 706756
2004 240 33.6 742736 713894
2005 241 33.8 747791 713711
2006 227 32.3 742409 702640
2007 109 37.9 705855 287784
Total 1166
Percentage of symptoms, reported at least once, by quarter before definite diagnosisFigure 1
Percentage of symptoms, reported at least once, by quarter before definite diagnosis.Page 5 of 9
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245 cases (71%) had at least one relevant investigation or
a referral to a gynaecologist recorded in the 12 months up
to and including the date of recorded diagnosis. The
median [IQR] time in weeks between a investigation or
referral and definite diagnosis was 7[3,14] for an
oophorectomy (n = 85), 8 [2,15] for a laparotomy or
laparoscopy (n = 53), 9[4,20] for an ultrasound (n = 105),
7.5 [3.5,15.5] for a CA125 test (n = 80) and 9 [4,21], for
referral to gynaecologist (n = 143). In the previous year 4
patients were recorded as having had had an oophorec-
tomy, 1 a laparotomy, 5 an ultrasound and 18 were
referred to a gynaecologist. The total number of cases
recorded as having a investigation or referral to a gynae-
cologist in the two years prior to diagnosis was 254(74%).
Since it seemed implausible that over 25% of cases had
been diagnosed without a prior investigation or referral
we checked whether these patients had a record of a letter
from a consultant or specialist, which might have con-
tained information on diagnostic tests. When cases who
had no record of a investigation or referral, but who did
have a Read code recording a letter (content unknown)
from a consultant or specialist were included as having
had a investigation or referral, the numbers increased to
285 (83%) in the previous year and 293 (85%) in the pre-
vious two years.
Sensitivity of time of diagnosis to definition of diagnosis 
date
Preliminary examination of individual records indicated
that first recorded code may not reliably indicate the date
of diagnosis. For example, 4 cases had been coded as hav-
ing an oophorectomy and 10 as an oncology or cancer
care referral at least 13 weeks before the first diagnosis
code. In addition, some cases had been coded with an
"ambiguous" code some time prior to being given a defi-
nite diagnosis code. In 19% of cases (n = 64) the GP
appeared to have already known that the patient had ovar-
ian or a closely related cancer prior to recording a definite
diagnosis (Figure 2). Of these, 47 cases had a prior ambig-
uous diagnosis, including 1 who had a diagnosis of "Car-
cinoma in situ of ovary" 31 months prior to the definite
diagnosis. This patient was kept in the study since the
diagnosis was within the prescribed study period. Twenty-
six patients, who had no record of a prior cancer diagno-
sis, had received cancer treatment or had been referred to
an oncologist prior to an "ambiguous" diagnosis. These
included 10 cases coded as "Seen in oncology clinic", 3 as
"Cancer care review" and 3 as "Chemotherapy" over 4
weeks before an "ambiguous" diagnosis. Four cases had
been coded as having an oophorectomy and 10 as an
oncology or cancer care referral at least 13 weeks before
the first diagnosis code. The median differences between a
previous and subsequent index date, for those whose
index dates were changed, were all within two months of
the previously defined index date, although in some cases
the differences were much greater (as shown by the IQR).
The median difference between Date 1 and Date 4, for the
229 cases who had a prior code for a investigation or refer-
ral for ovarian cancer was 8 [3,19] weeks.
For most of the ovarian cancer symptoms, the percentage
of cases recorded as having the symptom in the year prior
to diagnosis changed only slightly with each subsequent
definition of index date (Table 3), except for between Date
3 and 4 when the percentages decreased for all the most
commonly reported symptoms. The time between record-
ing one of the 4 most common symptom and diagnosis
changed very little for Dates 1 to 3 ((Table 3 and Figure 3).
However the time between recording a symptoms and
first investigation/referral was considerably shorter for
Date 4 than Dates 1–3 for most of these symptoms, with
the exception of constipation/change in bowel habits
where the time increased from 8.5 to 10 weeks (probably
due to the proportion being smaller before referral than
diagnosis).
Number of cases with index date change and median [IQR] difference between the earlier and later index date, according to the four definitions of i  tFigur  2
Number of cases with index date change and median [IQR] difference between the earlier and later index 
date, according to the four definitions of index date. Medians were calculated only for those with a index date change. 
*Date 2 for 6 cases with prior diagnosis of another cancer left unchanged. **Date 3 for 11 cases similarly left unchanged.Page 6 of 9
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A high proportion of the 344 patients with ovarian cancer
were recorded as reporting abdominal, gastrointestinal or
urogenital symptoms to their GP in the 6 months before
a definitely recorded diagnosis (Date 1) with half of these
being diagnosed within four months of first recorded
symptom. Our study confirms, using contemporaneous
observational data, that a substantial number of patients
do indeed consult with relevant symptoms prior to first
referral by the GP. The proportion of ovarian cancer
patients recorded as experiencing ovarian cancer symp-
toms is similar to that seen of other studies based on ret-
rospective analysis of patient records [13,25-28]. However
it is lower than those based on self-report, indicating that
symptoms may either be under-reported, or under-coded
in patient records.
For half the cases, the time from first symptom report to
first referral or investigation was 8 weeks or less. These
findings contrast with those of Kirwan et al's [13] retro-
spective study of GP patient notes, which found that 50%
of cases were referred to hospital directly after first con-
sulting their GP on ovarian cancer related symptoms.
However, since their estimates of delay were shorter than
those reported by studies that have examined primary care
delay in other cancers [8], their findings may have been
overly optimistic. The work described in this paper is the
first part of a study aiming to develop and test prognostic
models based on symptoms and consulting patterns. We
present a generalisable strategy for investigating inaccura-
cies in dating of diagnosis and their effect on estimates of
symptoms and delay in UK primary care databases. We
suggest that this or a similar explicitly stated strategy
should always be followed for studies which require the
dating of symptoms in relation to diagnosis, and that sen-
sitivity analyses should be undertaken for definitions of
diagnosis date. Although using different index dates based
on diagnosis made little difference to the percentages of
recorded symptoms and estimates of delay in this particu-
lar study, this may not always be the case depending on
the disease. We also recommend that, for studies investi-
gating primary care delay, the date of first investigation for
Box plots showing the distribution of time (weeks) between a symptom being first reported and a diagnosis according to the four definitions: Da e 1Figur  3
Box plots showing the distribution of time (weeks) between a symptom being first reported and a diagnosis 
according to the four definitions: Date 1. definite diagnosis, Date 2. diagnostic code plus closely related codes, Date 3. 
diagnosis code to include complication or treatment codes and Date 4. diagnostic code modified by investigation or referral 
code. Symptoms are ordered by frequency of occurrence
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index date, is much more relevant. Using the date of diag-
nosis as index date to investigate " red flag" symptoms (as
was done for example in [17]) may be misleading since
the actual diagnosis will be made in the hospital, and will
usually be recorded later by the GP.
An advantage of using electronic patient record databases
for epidemiological research is that they contain informa-
tion on large and representative numbers of patients that
is recorded during consultation, and therefore studies
based on these data are much less prone to recall or non-
response bias. However, the use of data that has been
recorded for administrative reasons, rather than for
research, is associated with a different set of problems;
some information may be missing or incomplete, or pos-
sibly only recorded in the (less accessible) free text notes.
It is clear that even for a major disease such as ovarian can-
cer not all events are (or can be) coded at the time of
definitive diagnosis or even at all. The lower incidence of
ovarian cancer codes in the GPRD records compared with
the ONS figures provides evidence of this under-recording
and concurs with a recent study of patients from 5 UK gen-
eral practices [25] which found that 20% of cancer cases
reported in the cancer registry could not be identified as
such in the GP records. In this study we looked only at
individual symptoms, rather than combinations, and
have no detailed analyses of temporal information on
sequences of events. Primary care records only allow us to
investigate primary care delay and we acknowledge that
there is likely to have been an under-recording of symp-
toms, either because the patient did not report them, or
because the GP did not code all the symptoms reported by
the patient. We have to date analysed only coded GPRD
data and have not examined the free text part of the
records which may contain further information on diag-
nosis (e.g. in the hospital letters) and are likely to also
contain important information on the severity of symp-
toms or on additional symptoms which have not been
coded.
Conclusion
If epidemiological and health services research based on
electronic records is to be of maximal public health bene-
fit, it will be important to develop methodologies for the
understanding and appropriately anonymised extraction
and use of information "concealed" within the free text.
Studies of the incidence of serious illness, and of survival
and patterns of care, will increasingly draw on the analysis
of routine health service records, which are not primarily
designed for research or audit, but to assist clinicians in
caring for their patients. It is therefore vital that strategies
are developed by which the impact of variation in clini-
cian recording patterns on epidemiological estimates can
be better understood, compared and adjusted for across
the spectrum of disease.
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Abdominal mass 19 6 20 5.5 19 5 15 0
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Any one of these symptoms 87 19.5 87 18 87 18 85 10Page 8 of 9
(page number not for citation purposes)
BMC Medical Research Methodology 2009, 9:42 http://www.biomedcentral.com/1471-2288/9/42Additional material
Acknowledgements
We would like to thank Amanda Nicholson for her very helpful comments 
on an early draft of the paper. This work was supported by the Wellcome 
Trust [086105/Z/08/Z ]. This study is based in part on data from the Full 
Feature General Practice Research Database obtained under licence from 
the UK Medicines and Healthcare Products Regulatory Agency. However, 
the interpretation and conclusions contained in this study are those of the 
authors alone. Access to the GPRD database was funded through the Med-
ical Research Council's licence agreement with MHRA.
References
1. Berrino F, Angelis RD, Sant M, Rosso S, Lasota MB, Coebergh JW,
Santaquilani M: Survival for eight major cancers and all cancers
combined for European adults diagnosed in 1995–99: results
of the EUROCARE-4 study.  Lancet Oncology 2007, 8(9):773-783.
2. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L,
Kunkler I, Grp WEW: Recent cancer survival in Europe: a
2000–02 period analysis of EUROCARE-4 data.  Lancet Oncol-
ogy 2007, 8:784-796.
3. Coleman MP, Quaresma M, Berrino F, Lutz JM, Angelis RD, Capocac-
cia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir
HK, Elwood JM, Tsukuma H, Koifman S, Silva GAE, Francisci S, San-
taquilani M, Verdecchia A, Storm HH, Young JL: Cancer survival in
five continents: a worldwide population-based study (CON-
CORD).  Lancet Oncology 2008, 9(8):730-756.
4. Richards M: EUROCARE-4 studies bring new data on cancer
survival.  Lancet Oncology 2007, 8(9):752-753.
5. Rachet B, Maringe C, Nur U, Quaresma M, Shah A, Woods LM, MPH
LE, Walters S, Forman D, Steward J, Coleman MP: Population-
based cancer survival trends in England and Wales up to
2007: an assessment of the NHS cancer plan for England.
Lancet Oncology 2009, 10(4):351-369.
6. Sikora K: Was the NHS cancer plan worth the effort?  Lancet
Oncology 2009, 10(4):312-313.
7. The National Awareness and Early Diagnosis Initiative
(NAEDI)   [http://info.cancerresearchuk.org/publicpolicy/naedi/]
8. Allgar VL, Neal RD: Delays in the diagnosis of six cancers: anal-
ysis of data from the National Survey of NHS Patients: Can-
cer.  British J Cancer 2005, 92(11):1959-1970.
9. UK CR: Ovarian Cancer statistics.   [http://info.cancerresear
chuk.org/cancerstats/types/ovary/)].
10. Horton R: Editorial: An experiment in earlier detection of
ovarian cancer.  The Lancet 2006, 369(9579):2051.
11. Goff BA, Mandel LS, Melancon CH, Muntz HG: Frequency of symp-
toms of ovarian cancer in women presenting to primary care
clinics.  Jama-journal Am Medical Association 2004, 291(22):2705-2712.
12. Bankhead CR, Kehoe ST, Austoker J: Symptoms associated with
diagnosis of ovarian cancer: a systematic review.  Bjog-an Int J
Obstetrics Gynaecology 2005, 112(7):857-865.
13. Kirwan JMJ, Tincello DG, Herod JJO, Frost O, Kingston RE: Effect of
delays in primary care referral on survival of women with
epithelial ovarian cancer: retrospective audit.  British Medical J
2002, 324(7330):148-151.
14. Allgar VL, Neal RD: General practictioners' management of
cancer in England: secondary analysis of data from the
National Survey of NHS Patients – Cancer.  European J Cancer
Care 2005, 14(5):409-416.
15. Goff BA, Mandel L, Muntz HG, Melancon CH: Ovarian carcinoma
diagnosis – Results of a National Ovarian Cancer Survey.
Cancer 2000, 89(10):2068-2075.
16. GPRD. Excellence in public health research   [http://www.gprd.com]
17. Jones R, Latinovic R, Charlton J, Gulliford MC: Alarm symptoms in
early diagnosis of cancer in primary care: cohort study using
General Practice Research Database.  British Medical J 2007,
334(7602):1040-1044.
18. Hamilton W, Kernick D: Clinical features of primary brain
tumours: a case-control study using electronic primary care
records.  British J General Practice 2007, 57:695-699.
19. Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T:
The importance of anaemia in diagnosing colorectal cancer:
a case-control study using electronic primary care records.
British J Cancer 2008, 98(2):323-327.
20. Lawrenson R, Logie J, Marks C: Risk of colorectal cancer in general
practice patients presenting with rectal bleeding, change in
bowel habit or anaemia.  European J Cancer Care 2006, 15(3):267-271.
21. Majeed A, Car J, Sheikh A: Accuracy and completeness of elec-
tronic patient records in primary care.  Fam Pract 2008,
25(4213-214 [http://fampra.oxfordjournals.org].
22. Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman
KM, Patras J, Mahony BS, Andersen MR: Development of an ovar-
ian cancer symptom index – Possibilities for earlier detec-
tion.  Cancer 2007, 109(2):221-227.
23. ONS: MB1 No 35. – Cancer Registration Statistics 2004.
[http://www.statistics.gov.uk/statbase/Product.asp?vlnk=8843].
24. ONS: MB1 No 36 – Cancer Registration Statistics 2004.
[http://www.statistics.gov.uk/statbase/Product.asp?vlnk=8843].
25. Pascoe SW, Neal RD, Heywood PL, Allgar VL, Miles JN, Stefoski-
Mikeljevic J: Identifying patients with a cancer diagnosis using
general practice medical records and Cancer Registry data.
Fam Pract 2008, 25(4215-220 [http://fampra.oxfordjournals.org/cgi/
content/abstract/25/4/215].
26. Ryerson AB, Eheman C, Burton J, McCall N, Blackman D, Subramanian S,
Richardson LC: Symptoms, diagnoses, and time to key diagnostic
procedures among older US women with ovarian cancer.
OBSTETRICS AND GYNECOLOGY 2007, 109(5):1053-1061. [2nd North
American Congress of Epidemiology, Seattle, WA, JUN 21–24, 2006]
27. Wynn ML, Chang S, Peipins LA: Temporal patterns of conditions
and symptoms potentially associated with ovarian cancer.
JOURNAL OF WOMENS HEALTH 2007, 16(7):971-986.
28. Yawn B, Barrette B, Wollan P: Ovarian cancer: The neglected
diagnosis.  MAYO CLINIC PROCEEDINGS 2004, 79(10):1277-1282.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2288/9/42/prepub
Additional file 1
Codelist for the four categories described in the section on sensitivity anal-
ysis. List of read codes and categories that were used for defining dates 1–4.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2288-9-42-S1.txt]
Additional file 2
Codelist for ovarian cancer symptoms. List of read codes and categories 
used in this paper to calculate the incidence of symptoms.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2288-9-42-S2.txt]
Additional file 3
Codelist for all types of cancers. The codelist that was used to identify 
prior cancers in other sites.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2288-9-42-S3.txt]
Additional file 4
Stata program for creating categories for investigations and referrals. 
The "do" file that was used for creating these categories.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2288-9-42-S4.zip]Page 9 of 9
(page number not for citation purposes)
